University of Turku, Martin Luther University Halle-Wittenberg, Servizio Galego de Saúde (SERGAS), University Medical Center Utrecht, University of Oxford, Imperial College London, Statens Serum Institute, Finnish Institute for Health and Welfare (THL), University of Edinburgh, National Institute for Public Health and the Environment (RIVM), Netherlands Institute for Health Services Research (NIVEL), Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, PENTA Foundation,
Centre for Health Economics Research and Modelling of Infectious Diseases (CHERMID)RSV causes severe disease in the very young and elderly and results in substantial healthcare costs. In the last 4 years, substantial progress has been made in development of products for active and passive immunization against RSV, with 19 products currently in clinical development. In 2017, we were funded by IMI to set up RESCEU project (Grant Agreement number 116019), which is the single largest consortium currently working on RSV and has ...